Zacks
  • Home
  • Analyst Bios
  • Research Reports
    • Companies by Analyst
      • Biotech - David Bautz, PhD
      • Bank & Finance – Ann Heffron, CFA, CPA
      • Biotech - John Vandermosten, CFA
      • Special Situations – Steven Ralston, CFA
      • Med-Tech – Brian Marckx, CFA
      • Technology – Lisa Thompson
      • Senior Analyst – M. Marin
      • Healthcare - Beth Senko, CFA
    • Companies by Name
  • Distribution
    • Institutional Distribution
    • Retail Distribution
    • Social Media
    • RSS Feeds
  • Our Partners
    • IR Firms
  • Contact
  • Subscribe
    • Free Weekly Digest
    • Zacks SCR Premium
Steven Ralston, CFA - Director of Research, Senior Special Situations Analyst

Steven Ralston, CFA, is the Senior Special Situations Analyst and Director of Research with Zacks Small-Cap Research, with over 30 years of experience in the securities and investment industry. He has covered companies within the Basic/Precious Materials, Industrials, Energy, Biotechnology, Real Estate, Cannabis, Packaged Foods, Consumer and Financial sectors since joining Zacks in 2004. Steven has been quoted in numerous publications including The Wall Street Journal, Barron's and Forbes, among others.



Prior to joining Zacks, Steven was the Director of Research at First National Bank of Maryland, portfolio manager of General Accident's domestic and Canadian equity pension portfolios, and co-manager of Blackrock's $2.3 billion Large Cap Growth Fund. Steven was a senior analyst at BlackRock from 1998-2003 and at First National Bank of Maryland from 1983-1995. He received his initial investment training at Merrill Lynch.



Steven graduated with a Bachelor of Science degree in Management Science from M.I.T and is a Chartered Financial Analyst (CFA®) charterholder.


Follow @RalstonCFA

Steven Ralston's Universe Includes





















>














Latest

Notes in the Press

March 4, 2021 BCLI: Awaiting BrainStorm’s Decision on NurOwn® BLA Filing…
March 3, 2021 Deep Yellow Limited Releases Positive PFS with Maiden Reserve on Tumas Project; Board Approves Proceeding Directly to a DFS
March 2, 2021 TRC: Recent Updates Imply Strong Positives For Development Plans
March 1, 2021 IDBA: Idex Biometrics Reports 2020 Earnings and Lists on NASDAQ
March 1, 2021 ELYS: Expanding Strategic Relationship to Leverage Growth Opportunities
March 1, 2021 ACHV: Data Presentation on Smoker and E-Cigarette User Attitudes and Quitting Perceptions
March 1, 2021 DSS Establishes a JV to Pursue a Digital Securities Exchange in the US and Adds Marketing Partners
March 1, 2021 KTRA: 2Q:21 Update & Target Price Increase
March 1, 2021 CVM: 1Q:21 Financial Update
March 1, 2021 BIOX: Bioceres Crop Solutions is poised to benefit from regulatory approvals in China for HB4 soybeans and in Brazil for HB4 wheat
 

Invalid login, please try again. You have retries remaining before your account will be locked.

Your account is locked and it will be unlocked automatically in minutes.

User ID:
Password:
Remember my ID:

COPYRIGHT © ZACKS INVESTMENT RESEARCH 2020
  • Disclaimer
  • Privacy Policy
  • Site Map
Tweet Follow @ZacksSmallCap
Powered By Q4 Inc. 5.52.0.6